Brett Sandercock - 09 May 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
09 May 2023
Transactions value $
-$795,000
Form type
4
Date filed
10 May 2023, 17:16
Previous filing
22 Feb 2023
Next filing
12 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$795K -3.43K -3.2% $232.05 104K 09 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted during an open trading window.
F2 Includes 62.3215 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan.